Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Ng, Hang Pong ^a   Zhou, Yun ^a   Song, Kejing ^a   Hodges, Craig A ^b   Drumm, Mitchell L ^b   Wang, Guoshun ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HYPOCHLOROUS ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BONE MARROW CELL; CELL KILLING; CELL LINEAGE; CFTR GENE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXON; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; IN VIVO STUDY; INNATE IMMUNITY; LUNG INFECTION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOSOME; PSEUDOMONAS AERUGINOSA; SYNTHESIS; ANIMAL; BACTERIAL PNEUMONIA; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; PHAGOCYTOSIS; PSEUDOMONAS INFECTION;

MUS;

ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; HYPOCHLOROUS ACID; MICE; MICE, KNOCKOUT; NEUTROPHILS; PHAGOCYTOSIS; PHAGOSOMES; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84906968886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106813     Document Type: Article

References (66)

1. Collins FS (1992) Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774-779.
2. Welsh MJ, Ramsey BW, Accurso F, Cutting G (2001) Cystic Fibrosis. In: Scriver CR, editor. Metabolic and Molecular Basis of Interited Disease. 8th ed. New York: McGraw-Hill. pp. 5121-5188.
3. Davis PB, Drumm M, Konstan MW (1996) Cystic fibrosis. Am J Respir Crit Care Med 154:1229-1256.
4. Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, et al. (2012) Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 11:363-382.
5. Downey DG, Bell SC, Elborn JS (2009) Neutrophils in cystic fibrosis. Thorax 64:81-88.
6. Rieber N, Hector A, Carevic M, Hartl D (2014) Current concepts of immune dysregulation in cystic fibrosis. Int J Biochem Cell Biol.
7. Hayes E, Pohl K, McElvaney NG, Reeves EP (2011) The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 59:97-112.
8. Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B (1999) Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? Mediators Inflamm 8:7-11.
9. Sajjan U, Corey M, Humar A, Tullis E, Cutz E, et al. (2001) Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol 50:535-546.
10. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, et al. (2007) Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13:1423-1430.
11. Su X, Looney MR, Su HE, Lee JW, Song Y, et al. (2011) Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. Inflamm Res.
12. Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, et al. (1996) Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 157:2728-2735.
13. Adib-Conquy M, Pedron T, Petit-Bertron AF, Tabary O, Corvol H, et al. (2008) Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 14:36-44.
14. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, et al. (2008) Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 105:4335-4339.
15. Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG (2011) Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 183:1517-1523.
16. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, et al. (2003) Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 284:L997-L1003.
17. Moriceau S, Lenoir G, Witko-Sarsat V (2010) In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Immun 2:260-266.
18. Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, et al. (2010) CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med 16:1018-1023.
19. Kettle AJ, Turner R, Gangell CL, Harwood DT, Khalilova IS, et al. (2014) Oxidation contributes to low glutathione in the airways of children with cystic fibrosis. Eur Respir J.
20. Pohl K, Hayes E, Keenan J, Henry M, Meleady P, et al. (2014) A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Blood.
21. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med 298:659-668.
22. Klebanoff SJ (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95:2131-2138.
23. Nauseef WM (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219:88-102.
24. Albrich JM, McCarthy CA, Hurst JK (1981) Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci USA 78:210-214.
25. Jiang Q, Griffin DA, Barofsky DF, Hurst JK (1997) Intraphagosomal chlorination dynamics and yields determined using unique fluorescent bacterial mimics. Chem Res Toxicol 10:1080-1089.
26. Klebanoff SJ (1970) Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 169:1095-1097.
27. Winterbourn CC, Hampton MB, Livesey JH, Kettle AJ (2006) Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem 281:39860-39869.
28. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93:185-198.
29. Yoshimura K, Nakamura H, Trapnell BC, Chu CS, Dalemans W, et al. (1991) Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res 19:5417-5423.
30. Painter RG, Valentine VG, Lanson NA, Jr., Leidal K, Zhang Q, et al. (2006) CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45:10260-10269.
31. Zhou Y, Song K, Painter RG, Aiken M, Reiser J, et al. (2013) Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils. J Innate Immun 5:219-230.
32. Painter RG, Marrero L, Lombard GA, Valentine VG, Nauseef WM, et al. (2010) CFTR-mediated halide transport in phagosomes of human neutrophils. J Leukoc Biol 87:933-942.
33. Painter RG, Bonvillain RW, Valentine VG, Lombard GA, La Place SG, et al. (2008) The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol 83:1345-1353.
34. Hodges CA, Cotton CU, Palmert MR, Drumm ML (2008) Generation of a conditional null allele for Cftr in mice. Genesis 46:546-552.
35. Bonfield TL, Hodges CA, Cotton CU, Drumm ML (2012) Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection. J Leukoc Biol 92:1111-1122.
36. Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, et al. (2005) Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25:1647-1653.
37. van Heeckeren AM, Schluchter MD (2002) Murine models of chronic Pseudomonas aeruginosa lung infection. Lab Anim 36:291-312.
38. Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, et al. (2008) In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol 190:2804-2813.
39. Kim J, Merry AC, Nemzek JA, Bolgos GL, Siddiqui J, et al. (2001) Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens. J Immunol 167:2808-2815.
40. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O (2004) Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 75:604-611.
41. Luo Y, Dorf ME (2001) Isolation of mouse neutrophils. Curr Protoc Immunol Chapter 3: Unit 3 20.
42. Cui L, Aleksandrov L, Chang XB, Hou YX, He L, et al. (2007) Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol 365:981-994.
43. Chen X, Lee KA, Ha EM, Lee KM, Seo YY, et al. (2011) A specific and sensitive method for detection of hypochlorous acid for the imaging of microbeinduced HOCl production. Chem Commun (Camb) 47:4373-4375.
44. Aiken ML, Painter RG, Zhou Y, Wang G (2012) Chloride transport in functionally active phagosomes isolated from Human neutrophils. Free Radic Biol Med 53:2308-2317.
45. Foote CS, Goyne TE, Lehrer RI (1983) Assessment of chlorination by human neutrophils. Nature 301:715-716.
46. Harrison JE, Schultz J (1976) Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251:1371-1374.
47. Weiss SJ, Klein R, Slivka A, Wei M (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 70:598-607.
48. Chapman AL, Hampton MB, Senthilmohan R, Winterbourn CC, Kettle AJ (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277:9757-9762.
49. Cohen TS, Prince A (2012) Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18:509-519.
50. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, et al. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2:29ra31.
51. Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V (2008) The role of neutrophils and monocytes in innate immunity. Contrib Microbiol 15:118-146.
52. Leguit RJ, van den Tweel JG (2010) The pathology of bone marrow failure. Histopathology 57:655-670.
53. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340.
54. Malech HL, Nauseef WM (1997) Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol 34:279-290.
55. Klein C (2011) Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol 29:399-413.
56. Di A, Brown ME, Deriy LV, Li C, Szeto FL, et al. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8:933-944.
57. Deriy LV, Gomez EA, Zhang G, Beacham DW, Hopson JA, et al. (2009) Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages. J Biol Chem 284:35926-35938.
58. Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggio MA, et al. (2011) Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS One 6:e19970.
59. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, et al. (2009) Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/-mice. Am J Respir Cell Mol Biol 40:295-304.
60. Deimann W (1984) Endogenous peroxidase activity in mononuclear phagocytes. Prog Histochem Cytochem 15:1-58.
61. Lehrer RI, Cline MJ (1969) Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48:1478-1488.
62. Lehrer RI, Hanifin J, Cline MJ (1969) Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature 223:78-79.
63. Hampton MB, Kettle AJ, Winterbourn CC (1996) Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect Immun 64:3512-3517.
64. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, et al. (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67:1828-1836.
65. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, et al. (2006) Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans. J Med Microbiol 55:1291-1299.
66. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, et al. (2000) Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 182:1276-1279.